blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4028771

EP4028771 - ASSAY [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  17.05.2024
Database last updated on 03.09.2024
FormerRequest for examination was made
Status updated on  17.06.2022
FormerThe international publication has been made
Status updated on  19.03.2021
Formerunknown
Status updated on  15.09.2020
Most recent event   Tooltip17.05.2024Withdrawal of applicationpublished on 19.06.2024  [2024/25]
Applicant(s)For all designated states
GlaxoSmithKline Biologicals S.A.
Rue de l'Institut, 89
1330 Rixensart / BE
[2022/29]
Inventor(s)01 / CHAPLET, Michael
GlaxoSmithKline Biologicals SA
Rue de l'Institut 89
1330 Rixensart / BE
02 / NORAIS, Nathalie
GlaxoSmithKline
Via Fiorentina 1
53100 Siena / IT
03 / RONDINI, Simona
GlaxoSmithKline
Via Fiorentina 1
53100 Siena / IT
04 / ROSSI PACCANI, Silvia
GlaxoSmithKline
Via Fiorentina 1
53100 Siena / IT
 [2022/29]
Representative(s)Broom, Ashley John
GlaxoSmithKline
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[2022/29]
Application number, filing date20767813.709.09.2020
[2022/29]
WO2020EP75128
Priority number, dateEP2019019671811.09.2019         Original published format: EP 19196718
[2022/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021048159
Date:18.03.2021
Language:EN
[2021/11]
Type: A1 Application with search report 
No.:EP4028771
Date:20.07.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 18.03.2021 takes the place of the publication of the European patent application.
[2022/29]
Search report(s)International search report - published on:EP18.03.2021
ClassificationIPC:G01N33/569
[2022/29]
CPC:
G01N33/56911 (EP,US); C07K16/1203 (US); C07K2317/33 (US);
G01N2333/212 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/29]
TitleGerman:TEST[2022/29]
English:ASSAY[2022/29]
French:DOSAGE[2022/29]
Entry into regional phase11.03.2022National basic fee paid 
11.03.2022Designation fee(s) paid 
11.03.2022Examination fee paid 
Examination procedure11.03.2022Examination requested  [2022/29]
11.03.2022Date on which the examining division has become responsible
21.10.2022Amendment by applicant (claims and/or description)
13.05.2024Application withdrawn by applicant  [2024/25]
Fees paidRenewal fee
21.09.2022Renewal fee patent year 03
20.09.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9828333  (UNIV TEXAS [US], et al) [X] 1-15 * chapter 5.0, pages 40 et seq.; examples *;
 [T]WO2015125118  (GLAXOSMITHKLINE BIOLOG SA [BE]);
 [T]WO2019170702  (GLAXOSMITHKLINE BIOLOGICALS SA [BE]) [T] * p16 first par;; claim 18; sequences 82,84 *
by applicantWO2007018463
 WO2015125118
    - HOICZYK E et al., EMBO J., (20000000), vol. 19, no. 22, pages 5989 - 99
    - AEBI C et al., Infect Immun., (19970000), vol. 65, no. 11, pages 4367 - 77
    - HELMINEN ME et al., J Infect Dis, (19940000), vol. 170, no. 4, pages 867 - 72
    - COPE LD et al., JBacteriol, (19990000), vol. 181, no. 13, pages 4026 - 34
    - TAN TT et al., J Infect Dis, (20050000), vol. 192, no. 6, pages 1029 - 38
    - TAN TT et al., J Infect Dis, (20060000), vol. 194, no. 4, pages 493 - 7
    - ATTIA AS et al., Infect Immun, (20050000), vol. 73, no. 4, pages 2400 - 10
    - VRIES et al., Microbiol Mol Biol Rev, (20090000), vol. 73, no. 3, pages 389 - 406
    - SAPEY ESTOCKLEY RA, "COPD exacerbations . 2: aetiology", Thorax, (20060000), vol. 61, no. 3, pages 250 - 8, XP009126262
    - ERB-DOWNWARD JR et al., PLoS One, (20110000), vol. 6, no. 2, page e16384
    - WILKINSON TMA et al., Thorax, (20170000), vol. 72, no. 10, pages 919 - 27
    - SETHI S et al., N Engl J Med, (20020000), vol. 347, no. 7, pages 465 - 71
    - ALAMOUDI OS et al., Respirology, (20070000), vol. 12, no. 2, pages 283 - 7
    - BANDI V et al., FEMS Immunol Med Microbiol, (20030000), vol. 37, no. 1, pages 69 - 75
    - BEASLEY V et al., Int J Chron Obstruct Pulmon Dis, (20120000), vol. 7, pages 555 - 69
    - HOLLIGER PHUDSON PJ, "Engineered antibody fragments and the rise of single domains", Nat Biotechnol, (20050000), vol. 23, no. 9, doi:10.1038/nbt1142, pages 1126 - 36, XP008076746

DOI:   http://dx.doi.org/10.1038/nbt1142
    - "EMBOSS: The European Molecular Biology Open Software Suite", Trends in Genetics, (20000000), vol. 16, no. 6, page 276,277
    - NEEDLEMAN, S. B.WUNSCH, C. D., J. Mol. Biol., (19700000), vol. 48, pages 443 - 453
    - BROOKS MJSEDILLO JLWAGNER NLAURENCE CAWANG WATTIA AS et al., "Modular arrangement of allelic variants explains the divergence in Moraxella catarrhalis UspA protein function", Infect Immun, (20080000), vol. 76, no. 11, pages 5330 - 40
    - COPE et al., J Bacteriol, (19990000), vol. 181, no. 13, pages 4026 - 34
    - BROOKS et al., Infect Immun, (20080000), vol. 76, no. 11, pages 5330 - 40
    - HILL DJWHITTLES CVIRJI M, PLoS One, (20120000), vol. 7, no. 9, page e45452
    - BOURNE S et al., "Acute exacerbation and respiratory infections in COPD (AERIS): protocol for a prospective, obervational cohort study", BMJ open, (20140000), vol. 4, no. 3, page e004546
    - "Rapid Development of Monoclonal Antibodies Using Repetitive Immunizations, Multiple Sites", ERIC P. DIXON., Cell Biology (Third Edition) A Laboratory Handbook, Academic Press, (20060000), vol. 1, pages 483 - 90
    - KWAKYOON et al., J Immunol Methods, (19960000), vol. 191, no. 1, pages 49 - 54
    - CABILLYRIGGS, Gene, (19850000), vol. 40, no. 1, pages 157 - 61
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.